About 8 results found for searched term "Human serum albumin" (0.124 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M40886 | Human serum albumin | Cytokines and Growth Factors |
| HSA | ||
| Human serum albumin is a protein found in human plasma. Its non-glycosylated, single-chain polypeptide contains 585 amino acids, has a molecular weight of 66 kD, transports fatty acids, bile pigments, amino acids, and steroid hormones, and serves as an excipient, stabilizer, and encapsulant. | ||
| M24560 | Ozoralizumab | TNF Receptor |
| ATN-103 | ||
| Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis. | ||
| M24655 | Sonelokimab | IL Receptor/Related |
| ALX 0761; M 1095 | ||
| Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research. | ||
| M24711 | Regavirumab | Anti-infection |
| MCA C23; TI-23 | ||
| Regavirumab (MCA C23) is a human monoclonal antibody against cytomegalovirus (CMV), human serum albumin (HSA) and amino acetic acid. | ||
| M24750 | Vobarilizumab | IL Receptor/Related |
| ALX-0061 | ||
| Vobarilizumab (ALX-0061) is an anti-IL-6R monoclonal antibody (mAb) (Kd: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis. | ||
| M25040 | Lerodalcibep | PCSK9 |
| LIB003 | ||
| Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases. | ||
| M25234 | Balugrastim | Others |
| CG 10639 | ||
| Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer. | ||
| M25379 | 5-Aminofluorescein | Fluorescent Dye |
| 5-AF | ||
| 5-Aminofluorescein (5-AF) is a fluorescence marker, covalently bound to human serum albumin. The excitation wavelength is 490 nm and the emission wavelength is 515 nm. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
